National Vision (EYE) Competitors $22.64 -1.53 (-6.33%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$22.64 0.00 (-0.02%) As of 09:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EYE vs. NVST, STVN, GKOS, BLCO, SLNO, IRTC, INSP, TMDX, PRCT, and WRBYShould you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. National Vision vs. Its Competitors Envista Stevanato Group Glaukos Bausch + Lomb Soleno Therapeutics iRhythm Technologies Inspire Medical Systems TransMedics Group PROCEPT BioRobotics Warby Parker Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation. Do analysts recommend NVST or EYE? Envista currently has a consensus price target of $20.92, indicating a potential upside of 3.25%. National Vision has a consensus price target of $24.73, indicating a potential upside of 9.22%. Given National Vision's stronger consensus rating and higher probable upside, analysts clearly believe National Vision is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33National Vision 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has stronger earnings & valuation, NVST or EYE? National Vision has lower revenue, but higher earnings than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvista$2.51B1.34-$1.12B$0.3263.33National Vision$1.82B0.98-$28.50M-$0.18-125.78 Which has more risk and volatility, NVST or EYE? Envista has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, National Vision has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Is NVST or EYE more profitable? Envista has a net margin of 2.11% compared to National Vision's net margin of -0.75%. Envista's return on equity of 4.84% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets Envista2.11% 4.84% 2.68% National Vision -0.75%3.56%1.49% Does the media prefer NVST or EYE? In the previous week, National Vision had 14 more articles in the media than Envista. MarketBeat recorded 24 mentions for National Vision and 10 mentions for Envista. National Vision's average media sentiment score of 1.04 beat Envista's score of 0.75 indicating that National Vision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive National Vision 8 Very Positive mention(s) 10 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryEnvista beats National Vision on 8 of the 15 factors compared between the two stocks. Get National Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EYE vs. The Competition Export to ExcelMetricNational VisionCONS PD IndustryStaples SectorNASDAQ ExchangeMarket Cap$1.79B$32.12B$16.01B$9.71BDividend YieldN/A2.69%3.17%4.12%P/E Ratio-125.7834.2618.6224.69Price / Sales0.981.7345.75104.79Price / Cash13.8416.1514.6828.01Price / Book2.188.476.095.76Net Income-$28.50M$1.23B$681.87M$267.05M7 Day Performance-9.69%-0.13%0.66%3.13%1 Month Performance-7.44%-2.06%-3.27%1.27%1 Year Performance120.23%26.71%6.03%22.83% National Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EYENational Vision2.9992 of 5 stars$22.64-6.3%$24.73+9.2%+120.2%$1.79B$1.82B-125.7813,411Positive NewsEarnings ReportAnalyst UpgradeNVSTEnvista3.4958 of 5 stars$20.73-0.3%$20.23-2.4%+25.2%$3.53B$2.51B-3.1712,300STVNStevanato Group2.0671 of 5 stars€25.77-2.8%N/A+15.3%€7.80B€1.19B50.535,521Positive NewsAnalyst RevisionGKOSGlaukos3.9357 of 5 stars$94.80+0.5%$134.67+42.1%-30.3%$5.39B$383.48M-40.00780Positive NewsBLCOBausch + Lomb2.7864 of 5 stars$14.47+1.0%$15.45+6.8%-13.1%$5.07B$4.79B-14.0513,500SLNOSoleno Therapeutics4.5554 of 5 stars$85.25-1.4%$108.70+27.5%+79.4%$4.36BN/A-18.4530Positive NewsEarnings ReportAnalyst RevisionIRTCiRhythm Technologies1.7583 of 5 stars$137.11+2.2%$137.30+0.1%+123.3%$4.28B$591.84M-43.672,000INSPInspire Medical Systems4.632 of 5 stars$130.72+1.4%$208.55+59.5%-59.0%$3.80B$802.80M60.241,246Positive NewsEarnings ReportTMDXTransMedics Group2.2688 of 5 stars$105.24-2.7%$129.88+23.4%-29.7%$3.66B$441.54M77.38210PRCTPROCEPT BioRobotics3.4214 of 5 stars$54.08-2.9%$84.13+55.6%-37.2%$3.08B$224.50M-31.81430Earnings ReportAnalyst UpgradeAnalyst RevisionGap UpWRBYWarby Parker1.9899 of 5 stars$24.10-1.2%$22.88-5.1%+77.6%$2.55B$771.32M-200.833,780Analyst ForecastGap Up Related Companies and Tools Related Companies NVST Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives SLNO Alternatives IRTC Alternatives INSP Alternatives TMDX Alternatives PRCT Alternatives WRBY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EYE) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Vision Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.